Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more
Agilent Technologies Inc (A) - Net Assets
Latest net assets as of October 2025: $6.74 Billion USD
Based on the latest financial reports, Agilent Technologies Inc (A) has net assets worth $6.74 Billion USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.73 Billion) and total liabilities ($5.99 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.74 Billion |
| % of Total Assets | 52.97% |
| Annual Growth Rate | 3.02% |
| 5-Year Change | 25.09% |
| 10-Year Change | 58.84% |
| Growth Volatility | 18.88 |
Agilent Technologies Inc - Net Assets Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Agilent Technologies Inc (1998–2025)
The table below shows the annual net assets of Agilent Technologies Inc from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-10-31 | $6.74 Billion | +14.29% |
| 2024-10-31 | $5.90 Billion | +0.91% |
| 2023-10-31 | $5.84 Billion | +10.18% |
| 2022-10-31 | $5.30 Billion | -1.56% |
| 2021-10-31 | $5.39 Billion | +10.59% |
| 2020-10-31 | $4.87 Billion | +2.63% |
| 2019-10-31 | $4.75 Billion | +3.87% |
| 2018-10-31 | $4.57 Billion | -5.46% |
| 2017-10-31 | $4.83 Billion | +13.93% |
| 2016-10-31 | $4.24 Billion | +2.07% |
| 2015-10-31 | $4.16 Billion | -21.35% |
| 2014-10-31 | $5.29 Billion | -0.04% |
| 2013-10-31 | $5.29 Billion | +2.01% |
| 2012-10-31 | $5.18 Billion | +20.13% |
| 2011-10-31 | $4.32 Billion | +33.37% |
| 2010-10-31 | $3.24 Billion | +29.13% |
| 2009-10-31 | $2.51 Billion | -2.07% |
| 2008-10-31 | $2.56 Billion | -20.87% |
| 2007-10-31 | $3.23 Billion | -11.62% |
| 2006-10-31 | $3.66 Billion | -10.34% |
| 2005-10-31 | $4.08 Billion | +14.35% |
| 2004-10-31 | $3.57 Billion | +26.38% |
| 2003-10-31 | $2.82 Billion | -38.97% |
| 2002-10-31 | $4.63 Billion | -18.24% |
| 2001-10-31 | $5.66 Billion | +7.48% |
| 2000-10-31 | $5.26 Billion | +55.68% |
| 1999-10-31 | $3.38 Billion | +11.91% |
| 1998-10-31 | $3.02 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Agilent Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 138900000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (October 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.39 Billion | 20.61% |
| Common Stock | $3.00 Million | 0.04% |
| Other Comprehensive Income | $-226.00 Million | -3.35% |
| Other Components | $5.58 Billion | 82.70% |
| Total Equity | $6.74 Billion | 100.00% |
Agilent Technologies Inc Competitors by Market Cap
The table below lists competitors of Agilent Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Carnival Plc ADS
NYSE:CUK
|
$31.61 Billion |
|
Ferrovial SE
NASDAQ:FER
|
$31.67 Billion |
|
Carnival Corporation
NYSE:CCL
|
$31.73 Billion |
|
State Street Corp
NYSE:STT
|
$31.73 Billion |
|
United Overseas Bank Limited
PINK:UOVEF
|
$31.36 Billion |
|
Japan Tobacco Inc
PINK:JAPAF
|
$31.32 Billion |
|
ESSILORLUXOTTICA 1/2/O.N.
F:ESLC
|
$31.26 Billion |
|
Kotak Mahindra Bank Limited
NSE:KOTAKBANK
|
$31.22 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Agilent Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,898,000,000 to 6,741,000,000, a change of 843,000,000 (14.3%).
- Net income of 434,000,000 contributed positively to equity growth.
- Dividend payments of 282,000,000 reduced retained earnings.
- Share repurchases of 425,000,000 reduced equity.
- Other comprehensive income increased equity by 79,000,000.
- Other factors increased equity by 1,037,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $434.00 Million | +6.44% |
| Dividends Paid | $282.00 Million | -4.18% |
| Share Repurchases | $425.00 Million | -6.3% |
| Other Comprehensive Income | $79.00 Million | +1.17% |
| Other Changes | $1.04 Billion | +15.38% |
| Total Change | $- | 14.29% |
Book Value vs Market Value Analysis
This analysis compares Agilent Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.71x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.98x to 4.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-10-31 | $6.58 | $111.83 | x |
| 1999-10-31 | $7.39 | $111.83 | x |
| 2000-10-31 | $11.57 | $111.83 | x |
| 2001-10-31 | $12.36 | $111.83 | x |
| 2002-10-31 | $9.95 | $111.83 | x |
| 2003-10-31 | $5.97 | $111.83 | x |
| 2004-10-31 | $7.28 | $111.83 | x |
| 2005-10-31 | $8.16 | $111.83 | x |
| 2006-10-31 | $8.27 | $111.83 | x |
| 2007-10-31 | $7.97 | $111.83 | x |
| 2008-10-31 | $6.90 | $111.83 | x |
| 2009-10-31 | $7.24 | $111.83 | x |
| 2010-10-31 | $9.14 | $111.83 | x |
| 2011-10-31 | $12.14 | $111.83 | x |
| 2012-10-31 | $14.68 | $111.83 | x |
| 2013-10-31 | $15.32 | $111.83 | x |
| 2014-10-31 | $15.63 | $111.83 | x |
| 2015-10-31 | $12.40 | $111.83 | x |
| 2016-10-31 | $12.89 | $111.83 | x |
| 2017-10-31 | $14.80 | $111.83 | x |
| 2018-10-31 | $14.05 | $111.83 | x |
| 2019-10-31 | $14.93 | $111.83 | x |
| 2020-10-31 | $15.62 | $111.83 | x |
| 2021-10-31 | $17.55 | $111.83 | x |
| 2022-10-31 | $17.68 | $111.83 | x |
| 2023-10-31 | $19.75 | $111.83 | x |
| 2024-10-31 | $20.27 | $111.83 | x |
| 2025-10-31 | $23.74 | $111.83 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Agilent Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.44%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.32%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 1.89x
- Recent ROE (6.44%) is below the historical average (12.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 8.50% | 3.23% | 1.59x | 1.65x | $-45.20 Million |
| 1999 | 15.14% | 7.50% | 1.25x | 1.61x | $173.80 Million |
| 2000 | 14.38% | 8.09% | 1.12x | 1.58x | $230.50 Million |
| 2001 | 2.97% | 2.00% | 1.05x | 1.41x | $-397.90 Million |
| 2002 | -22.30% | -17.17% | 0.73x | 1.77x | $-1.49 Billion |
| 2003 | -72.88% | -46.06% | 0.71x | 2.23x | $-2.34 Billion |
| 2004 | 10.34% | 5.14% | 1.02x | 1.98x | $12.10 Million |
| 2005 | 3.46% | 3.01% | 0.69x | 1.65x | $-267.10 Million |
| 2006 | 90.65% | 66.50% | 0.67x | 2.02x | $2.94 Billion |
| 2007 | 19.73% | 11.77% | 0.72x | 2.34x | $314.60 Million |
| 2008 | 27.08% | 12.00% | 0.78x | 2.91x | $437.10 Million |
| 2009 | -1.24% | -0.69% | 0.59x | 3.04x | $-281.60 Million |
| 2010 | 21.19% | 12.56% | 0.56x | 3.00x | $361.20 Million |
| 2011 | 23.49% | 15.30% | 0.73x | 2.10x | $581.20 Million |
| 2012 | 22.25% | 16.81% | 0.65x | 2.03x | $634.80 Million |
| 2013 | 13.70% | 18.59% | 0.36x | 2.02x | $195.40 Million |
| 2014 | 10.39% | 13.56% | 0.38x | 2.04x | $20.60 Million |
| 2015 | 9.65% | 9.93% | 0.54x | 1.80x | $-14.50 Million |
| 2016 | 10.85% | 10.95% | 0.54x | 1.84x | $35.90 Million |
| 2017 | 14.17% | 15.30% | 0.53x | 1.75x | $201.40 Million |
| 2018 | 6.92% | 6.43% | 0.58x | 1.87x | $-140.70 Million |
| 2019 | 22.56% | 20.74% | 0.55x | 1.99x | $596.20 Million |
| 2020 | 14.75% | 13.47% | 0.55x | 1.98x | $231.70 Million |
| 2021 | 22.45% | 19.15% | 0.59x | 1.99x | $671.10 Million |
| 2022 | 23.64% | 18.31% | 0.65x | 1.99x | $723.50 Million |
| 2023 | 21.21% | 18.15% | 0.63x | 1.84x | $655.50 Million |
| 2024 | 21.85% | 19.80% | 0.55x | 2.01x | $699.20 Million |
| 2025 | 6.44% | 23.32% | 0.15x | 1.89x | $-240.10 Million |
Industry Comparison
This section compares Agilent Technologies Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $74,315,860
- Average return on equity (ROE) among peers: -76.92%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Agilent Technologies Inc (A) | $6.74 Billion | 8.50% | 0.89x | $31.54 Billion |
| Amer Bio Medica (ABMC) | $2.66 Million | -28.23% | 1.26x | $3.55K |
| ADCNF (ADCNF) | $852.85 Million | 37.00% | 2.65x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.49 Million | -115.35% | 0.92x | $2.00 Million |
| ANGLE plc (ANPCF) | $3.82 Million | -94.09% | 0.43x | $34.42 Million |
| SeqLL Inc. (ATLN) | $4.37 Million | -93.77% | 0.93x | $36.29K |
| Avricore Health Inc (AVCRF) | $-37.20K | 0.00% | 0.00x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $3.76 Million | -397.87% | 1.13x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $52.50 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-4.04 Million | 0.00% | 0.00x | $5.08 Million |